Evotec SE

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005664809
EUR
5.60
0.03 (0.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Evotec SE Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-236.00
-103.00
-180.00
221.00
10.00
30.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-68.00
-9.00
119.00
-2.00
-36.00
-68.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
17.00
33.00
203.00
122.00
44.00
42.00
Cash Flow from Investing Activities
-76.00
-23.00
-415.00
-243.00
-155.00
-86.00
Cash Flow from Financing Activities
-155.00
84.00
-52.00
398.00
246.00
211.00
Net Cash Inflow / Outflow
-204.00
95.00
-284.00
276.00
145.00
167.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
9.00
0.00
-19.00
0.00
9.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Evotec SE
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
-236.527
3536
-3,772.00
-106.69%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-68.207
-310
242.00
78.00%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
17.947
4586
-4,569.00
-99.61%
Cash Flow from Investing Activities
-76.834
-3050
2,974.00
97.48%
Cash Flow from Financing Activities
-155.501
-985
830.00
84.21%
Net Cash Inflow / Outflow
-204.522
535
-739.00
-138.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
9.866
-16
25.00
161.66%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -47.14% vs -83.28% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
17.95
33.95
-47.14%